Non-alcoholic Fatty Liver Disease Concept

subject area of

• A Metabolic Enhancer Protects against Diet-Induced Obesity and Liver Steatosis and Corrects a Pro-Atherogenic Serum Profile in Mice  Journal Articles
• A Multi-Ingredient Supplement Protects against Obesity and Infertility in Western Diet-Fed Mice  Journal Articles
• AMPK as a Therapeutic Target for Treating Metabolic Diseases  Journal Articles
• Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models  Journal Articles
• Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood  Journal Articles
• Adverse metabolic effects of a hypercaloric, high-fat diet in rodents precede observable changes in body weight  Journal Articles
• Adverse metabolic phenotype of adolescent girls with non‐alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys  Journal Articles
• Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats  Journal Articles
• Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes  Journal Articles
• Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients  Journal Articles
• Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways  Journal Articles
• Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice  Journal Articles
• Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study  Journal Articles
• Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis  Journal Articles
• Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease  Journal Articles
• Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis  Journal Articles
• Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials  Journal Articles
• Effects of ambient air pollution on obesity and ectopic fat deposition: a protocol for a systematic review and meta-analysis  Journal Articles
• Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review  Journal Articles
• Exposure to high fructose corn syrup during adolescence in the mouse alters hepatic metabolism and the microbiome in a sex‐specific manner  Journal Articles
• Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation  Journal Articles
• Fluoxetine-induced hepatic lipid accumulation is linked to elevated serotonin production  Journal Articles
• Fluoxetine‐induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15‐deoxy‐Δ^12,14PGJ₂  Journal Articles
• Fructose, pregnancy and later life impacts  Journal Articles
• Fructose-Containing Sugars, Blood Pressure, and Cardiometabolic Risk: A Critical Review  Journal Articles
• GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury  Journal Articles
• GDF15 promotes weight loss by enhancing energy expenditure in muscle  Journal Articles
• GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease  Journal Articles
• Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)  Journal Articles
• High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage Pathway  Journal Articles
• Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease  Journal Articles
• Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials  Journal Articles
• Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes  Journal Articles
• Increased incidence of non‐alcoholic fatty liver disease in male rat offspring exposed to fluoxetine during fetal and neonatal life involves the NLRP3 inflammasome and augmented de novo hepatic lipogenesis  Journal Articles
• Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis  Journal Articles
• Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia  Journal Articles
• Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms.  Journal Articles
• Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiota  Journal Articles
• Maternal taurine supplementation attenuates maternal fructose-induced metabolic and inflammatory dysregulation and partially reverses adverse metabolic programming in offspring  Journal Articles
• Meta-Analysis of Nonalcoholic Fatty Liver Disease and Incident Heart Failure  Journal Articles
• Metabolic Dysfunction-Associated Fatty Liver Disease Is Associated with the Risk of Incident Cardiovascular Disease: A Prospective Cohort Study in Xinjiang.  Journal Articles
• Metabolic dysfunction following weight regain compared to initial weight gain in a high-fat diet-induced obese mouse model  Journal Articles
• NLRP3 Inflammasome Modulates Post-Burn Lipolysis and Hepatic Fat Infiltration via Fatty Acid Synthase  Journal Articles
• NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice  Journal Articles
• Nontargeted Serum Lipid Profiling of Nonalcoholic Steatohepatitis by Multisegment Injection–Nonaqueous Capillary Electrophoresis–Mass Spectrometry: A Multiplexed Separation Platform for Resolving Ionic Lipids  Journal Articles
• Offspring of Mothers Fed a High Fat Diet Display Hepatic Cell Cycle Inhibition and Associated Changes in Gene Expression and DNA Methylation  Journal Articles
• Overstated Associations Between Fructose and Nonalcoholic Fatty Liver Disease  Journal Articles
• PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease  Journal Articles
• Reply  Journal Articles
• Restoration of the ER stress response protein TDAG51 in hepatocytes mitigates NAFLD in mice  Journal Articles
• Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease  Journal Articles
• Treatment of nonalcoholic fatty liver disease: role of AMPK  Journal Articles
• Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease  Journal Articles
• Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity  Journal Articles
• Western diet consumption through early life induces microvesicular hepatic steatosis in association with an altered metabolome in low birth weight Guinea pigs  Journal Articles
• [Comparative study of clinicopathological features, and risk factors of advanced fibrosis between genders with non-alcoholic fatty liver disease].  Journal Articles